Unusual 11 Mid-Day Movers 08/10: (PEGA) (GRZ) (TAT) Higher; (ANX) (PRMW) (MOTR) Lower
Tweet
Share
E-mail
Get Alerts ANX Hot Sheet
Join SI Premium – FREE
ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX) 58.3% LOWER; is getting pummeled today, following receipt of a complete response letter from the U.S. Food and Drug Administration (FDA) regarding the Company's New Drug Application (NDA) for Exelbine (vinorelbine injectable emulsion) for the treatment of non-small cell lung cancer.
Primo Water Corporation (Nasdaq: PRMW) 55.5% LOWER; reported Q2 EPS of ($0.01), 6 cents worse than the analyst estimate of $0.05. Revenue for the quarter came in at $20.7 million versus the consensus estimate of $25.17 million. Sees Q3 2011 EPS of ($0.06) to ($0.03), versus the consensus of $0.07. Sees Q3 2011 revenue of $24 to $26 million, versus the consensus of $36.09 million. Sees FY2012 EPS of $0.63 to $0.72, versus the consensus of $0.23. Sees FY2011 revenue of $177 to $187 million, versus the consensus of $115.81 million.
MOTRICITY, Inc. (Nasdaq: MOTR) 53.2% LOWER; reported Q2 EPS of $0.04, 5 cents worse than the analyst estimate of $0.09. Revenue for the quarter came in at $34.6 million versus the consensus estimate of $37.08 million. Sees Q3 2011 revenue of $31.5-$32.5 million, versus the consensus of $45.48 million.
IntraLinks Holdings (NYSE: IL) 44.8% LOWER; reported Q2 EPS of $0.10, in-line with the analyst estimate of $0.10. Revenue for the quarter came in at $53.3 million versus the consensus estimate of $52.16 million. Sees Q3 2011 EPS of $0.11 to $0.13, versus the consensus of $0.14. Sees Q3 2011 revenue of $54-$56 million, versus the consensus of $54.92 million. Sees FY2011 EPS of $0.50 to $0.57, versus the consensus of $0.52. Sees FY2011 revenue of $215to $225 million, versus the consensus of $217.8 million.
Epocrates, Inc. (Nasdaq: EPOC) 39.7% LOWER; reported Q2 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $27.9 million versus the consensus estimate of $29.59 million. Sees FY2011 EPS of $0.01 to $0.10, versus the consensus of $0.09. Sees FY2011 revenue of $115 to $120 million, versus prior guidance of $122 to $125 million and the consensus of $123 million.
Pegasystems, Inc. (Nasdaq: PEGA) 21.0% HIGHER; reported Q2 EPS of $0.16, 2 cents better than the analyst estimate of $0.14. Revenue for the quarter came in at $103.5 million versus the consensus estimate of $101.57 million.
TransAtlantic Petroleum Ltd. (NYSE: TAT) 22.9% HIGHER; reports Q2 loss of $0.03, 1 cent better than the analyst estimate of ($0.04). Revenue for the quarter came in at $35.51 million, versus the consensus estimate of $50.65 million. The stock tumbled 26 percent yesterday and is down sharply over the last several weeks.
Gold Reserve Inc. (AMEX: GRZ) 18.6% HIGHER; moving higher today as gold prices hit a new record high above $1800 per ounce.
Cree, Inc. (Nasdaq: CREE) 15.3% HIGHER; reported Q4 EPS of $0.24, 3 cemts worse than the analyst estimate of $0.27. Revenue for the quarter came in at $243 million versus the consensus estimate of $233.82 million. Sees Q1 2012 revenue of $245 to $255 million, versus the consensus of $253 million.
Biolase Technology, Inc. (Nasdaq: BLTI) 15.1% HIGHER; reported Q2 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $12.08 million versus the consensus estimate of $12.01 million.
Mistras Group (NYSE: MG) 11.3% HIGHER; reported Q4 EPS of $0.25, 3 cents better than the analyst estimate of $0.22. Revenue for the quarter came in at $102.1 million versus the consensus estimate of $94.76 million. Sees FY2012 revenue of $375-$390 million, versus the consensus of $377.12 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers..
Primo Water Corporation (Nasdaq: PRMW) 55.5% LOWER; reported Q2 EPS of ($0.01), 6 cents worse than the analyst estimate of $0.05. Revenue for the quarter came in at $20.7 million versus the consensus estimate of $25.17 million. Sees Q3 2011 EPS of ($0.06) to ($0.03), versus the consensus of $0.07. Sees Q3 2011 revenue of $24 to $26 million, versus the consensus of $36.09 million. Sees FY2012 EPS of $0.63 to $0.72, versus the consensus of $0.23. Sees FY2011 revenue of $177 to $187 million, versus the consensus of $115.81 million.
MOTRICITY, Inc. (Nasdaq: MOTR) 53.2% LOWER; reported Q2 EPS of $0.04, 5 cents worse than the analyst estimate of $0.09. Revenue for the quarter came in at $34.6 million versus the consensus estimate of $37.08 million. Sees Q3 2011 revenue of $31.5-$32.5 million, versus the consensus of $45.48 million.
IntraLinks Holdings (NYSE: IL) 44.8% LOWER; reported Q2 EPS of $0.10, in-line with the analyst estimate of $0.10. Revenue for the quarter came in at $53.3 million versus the consensus estimate of $52.16 million. Sees Q3 2011 EPS of $0.11 to $0.13, versus the consensus of $0.14. Sees Q3 2011 revenue of $54-$56 million, versus the consensus of $54.92 million. Sees FY2011 EPS of $0.50 to $0.57, versus the consensus of $0.52. Sees FY2011 revenue of $215to $225 million, versus the consensus of $217.8 million.
Epocrates, Inc. (Nasdaq: EPOC) 39.7% LOWER; reported Q2 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $27.9 million versus the consensus estimate of $29.59 million. Sees FY2011 EPS of $0.01 to $0.10, versus the consensus of $0.09. Sees FY2011 revenue of $115 to $120 million, versus prior guidance of $122 to $125 million and the consensus of $123 million.
Pegasystems, Inc. (Nasdaq: PEGA) 21.0% HIGHER; reported Q2 EPS of $0.16, 2 cents better than the analyst estimate of $0.14. Revenue for the quarter came in at $103.5 million versus the consensus estimate of $101.57 million.
TransAtlantic Petroleum Ltd. (NYSE: TAT) 22.9% HIGHER; reports Q2 loss of $0.03, 1 cent better than the analyst estimate of ($0.04). Revenue for the quarter came in at $35.51 million, versus the consensus estimate of $50.65 million. The stock tumbled 26 percent yesterday and is down sharply over the last several weeks.
Gold Reserve Inc. (AMEX: GRZ) 18.6% HIGHER; moving higher today as gold prices hit a new record high above $1800 per ounce.
Cree, Inc. (Nasdaq: CREE) 15.3% HIGHER; reported Q4 EPS of $0.24, 3 cemts worse than the analyst estimate of $0.27. Revenue for the quarter came in at $243 million versus the consensus estimate of $233.82 million. Sees Q1 2012 revenue of $245 to $255 million, versus the consensus of $253 million.
Biolase Technology, Inc. (Nasdaq: BLTI) 15.1% HIGHER; reported Q2 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $12.08 million versus the consensus estimate of $12.01 million.
Mistras Group (NYSE: MG) 11.3% HIGHER; reported Q4 EPS of $0.25, 3 cents better than the analyst estimate of $0.22. Revenue for the quarter came in at $102.1 million versus the consensus estimate of $94.76 million. Sees FY2012 revenue of $375-$390 million, versus the consensus of $377.12 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers..
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
